Microencapsulation of genetically engineered fibroblasts secreting nerve growth factor

Area of Science:

• Biotechnology
• Neuroscience
• Tissue Engineering

Background:

• Central nervous system (CNS) injuries require innovative therapeutic strategies.
• Nerve growth factor (NGF) is crucial for neuronal survival and function.
• Improving cell transplantation methods is essential for effective regenerative medicine.

Purpose of the Study:

• To encapsulate genetically modified fibroblasts producing NGF into biocompatible spheres.
• To assess the viability and sustained NGF secretion of encapsulated cells.
• To evaluate the biological activity of secreted NGF for potential CNS therapies.

Main Methods:

• Genetically engineered rat fibroblasts producing NGF were encapsulated in an alginate-polylysine gel.
• Cell suspension was extruded into calcium chloride to form spheres.
• Morphological analysis using light and electron microscopy was performed.
• NGF levels in culture media were quantified over 60 days.
• Biological activity of NGF was confirmed by assessing choline acetyltransferase (ChAT) induction.

Main Results:

• Encapsulated fibroblasts remained viable and secreted NGF continuously for at least 60 days.
• Spheres exhibited a homogenous membrane without protruding cells.
• Secreted NGF demonstrated biological activity by inducing ChAT in target neurons.

Conclusions:

• Microencapsulation is a viable method for maintaining fibroblast viability and NGF secretion.
• This approach offers a promising strategy for delivering trophic factors to the CNS.
• Further in vivo studies are warranted to explore therapeutic applications for CNS injuries.